83 related articles for article (PubMed ID: 2864890)
21. Duration of oral procaterol protection from methacholine-induced bronchial obstruction.
De Candussio G; Franchi D; Manini G; Arossa W; Castello D
Int J Clin Pharmacol Res; 1986; 6(5):403-7. PubMed ID: 2877955
[TBL] [Abstract][Full Text] [Related]
22. Prevention of exercise-induced bronchospasm in asthmatic children. Effect of aerosol and oral procaterol hydrochloride.
Morooka T; Nishima S; Ota S
J Asthma; 1987; 24(6):335-46. PubMed ID: 2965139
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
Goldstein MF; Chervinsky P
Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and duration of action of oral procaterol in asthmatic children after single administration of different dosages.
Boner AL; Zanotto CE; Piacentini G; Miglioranzi P; Richelli C; Sette L
J Asthma; 1990; 27(1):21-30. PubMed ID: 2137815
[TBL] [Abstract][Full Text] [Related]
25. Effect of increasing dosage of an inhaled beta-2 specific agonist on pulmonary function, tremor, and cardiovascular indices.
Tinkelman DG; Lutz C
Ann Allergy; 1992 Jan; 68(1):23-6. PubMed ID: 1346562
[TBL] [Abstract][Full Text] [Related]
26. Prednisolone oral solution plus inhaled procaterol for acute asthma in children: a double-blind randomized controlled trial.
Huang LH; Shyur SD; Wen DC; Chang YC; Ma YC; Lin SC; Wu WC; Wu JY
Acta Paediatr Taiwan; 2007; 48(5):257-62. PubMed ID: 18254574
[TBL] [Abstract][Full Text] [Related]
27. Budesonide + formoterol: new dose regimen. Asthma attacks: a step backwards.
Prescrire Int; 2008 Apr; 17(94):57. PubMed ID: 18516807
[TBL] [Abstract][Full Text] [Related]
28. Inhaled procaterol versus salbutamol in bronchial asthma.
Liippo K; Silvasti M; Tukiainen H
Eur J Clin Pharmacol; 1991; 40(4):417-8. PubMed ID: 1828765
[TBL] [Abstract][Full Text] [Related]
29. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.
Milgrom H; Skoner DP; Bensch G; Kim KT; Claus R; Baumgartner RA;
J Allergy Clin Immunol; 2001 Dec; 108(6):938-45. PubMed ID: 11742271
[TBL] [Abstract][Full Text] [Related]
30. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of procaterol aerosol as an aerosolized beta 2-adrenergic bronchodilator in conscious guinea pigs].
Arai Y; Nitta K; Shida T
Arerugi; 1985 Nov; 34(11):999-1005. PubMed ID: 2867754
[No Abstract] [Full Text] [Related]
32. [Comparison of the bronchodilating activity of procaterol and nicardipine in chronic forms of bronchial asthma].
Ardizzi A; Barberis S; Giorgis GE; Oliaro A; Galietti F; Ciotta D
Minerva Med; 1987 Oct; 78(19):1433-5. PubMed ID: 2959882
[TBL] [Abstract][Full Text] [Related]
33. Effects of albuterol and procaterol on exercise-induced asthma.
Shapiro GG; Kemp JP; DeJong R; Chapko M; Bierman CW; Altman LC; Furukawa CT; Meltzer E; Orgel A; Pierson WE
Ann Allergy; 1990 Oct; 65(4):273-6. PubMed ID: 2145791
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of tremor and efficacy of oral procaterol in adult patients with asthma.
Tinkelman DG; DeJong R; Lutz C; Spangler DL
J Allergy Clin Immunol; 1990 Apr; 85(4):719-28. PubMed ID: 1969869
[TBL] [Abstract][Full Text] [Related]
35. [Inhalation therapy for bronchial asthma. A. Bronchodilator--beta 2-stimulant].
Takagi K; Yamaki K; Satake T; Awaya M
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Nov; 28(11):1405-9. PubMed ID: 2290222
[TBL] [Abstract][Full Text] [Related]
36. Double-blind trial of oral carbuterol in bronchial asthma.
Miller J; Wallace D; Grieco MH; Frenkel R; Larsen K
Ann Allergy; 1977 Jul; 39(1):12-7. PubMed ID: 18957
[TBL] [Abstract][Full Text] [Related]
37. Comparison between oral procaterol and salbutamol in patients with bronchial asthma.
Tukiainen H; Jaakkola J; Torkko M; Terho EO
Curr Med Res Opin; 1988; 11(4):236-41. PubMed ID: 2975204
[TBL] [Abstract][Full Text] [Related]
38. Eformoterol and bronchial hyperresponsiveness in mild asthma.
Chung KF
Br J Clin Pract Suppl; 1995 Sep; 81():14-5. PubMed ID: 8546888
[No Abstract] [Full Text] [Related]
39. Formoterol and asthma exacerbations.
van der Molen T
Chest; 2004 Apr; 125(4):1591. PubMed ID: 15078783
[No Abstract] [Full Text] [Related]
40. The utility of a long-acting sympathomimetic agent, procaterol, for nocturnal asthma.
Baughman RP; Loudon RG
Chest; 1988 Feb; 93(2):285-8. PubMed ID: 2962837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
